pubmed-article:15269840 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:15269840 | lifeskim:mentions | umls-concept:C1956346 | lld:lifeskim |
pubmed-article:15269840 | lifeskim:mentions | umls-concept:C0439849 | lld:lifeskim |
pubmed-article:15269840 | lifeskim:mentions | umls-concept:C0229671 | lld:lifeskim |
pubmed-article:15269840 | lifeskim:mentions | umls-concept:C0026473 | lld:lifeskim |
pubmed-article:15269840 | lifeskim:mentions | umls-concept:C0108747 | lld:lifeskim |
pubmed-article:15269840 | lifeskim:mentions | umls-concept:C1456820 | lld:lifeskim |
pubmed-article:15269840 | lifeskim:mentions | umls-concept:C0441889 | lld:lifeskim |
pubmed-article:15269840 | lifeskim:mentions | umls-concept:C1367477 | lld:lifeskim |
pubmed-article:15269840 | lifeskim:mentions | umls-concept:C1414555 | lld:lifeskim |
pubmed-article:15269840 | pubmed:issue | 2 | lld:pubmed |
pubmed-article:15269840 | pubmed:dateCreated | 2004-7-22 | lld:pubmed |
pubmed-article:15269840 | pubmed:abstractText | Monocytes play a central role in the inflammatory disease atherosclerosis. CD14+CD16+ monocytes are considered proinflammatory monocytes, as they have an increased capacity to produce proinflammatory cytokines, such as TNF-alpha, and are elevated in various inflammatory diseases. We hypothesized that patients with coronary artery disease (CAD) have increased levels of CD14+CD16+ monocytes, and that CD14+CD16+ monocytes are associated with inflammation markers. We investigated CD14+CD16+ monocytes in 247 patients with CAD and 61 control subjects using flow cytometry. In addition serum concentrations of TNF-alpha, IL-6, and Hs-CRP were assessed. Patients with CAD had higher levels of CD14+CD16+ monocytes than controls (13.6% versus 11.4%; p<0.001). Logistic regression analysis including quartiles of CD14+CD16+ monocytes showed that CD14+CD16+ monocytes were associated with prevalence of CAD (OR 4.9, 95% CI 2.5-19.1, for subjects in the fourth quartile in comparison to subjects in the first quartile). The association between CD14+CD16+ monocytes and CAD remained independently significant after adjustment for most potential confounders (OR 5.0, 95% CI 1.2-20.0). Serum concentrations of TNF-alpha were elevated in subjects within the highest quartiles of CD14+CD16+ monocytes (p=0.018). Our study showed that increased numbers of CD14+CD16+ monocytes are associated with coronary atherosclerosis and TNF-alpha. In accordance, recent animal studies suggest a possibly important role of these monocytes in the development of atherosclerosis. | lld:pubmed |
pubmed-article:15269840 | pubmed:language | eng | lld:pubmed |
pubmed-article:15269840 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:15269840 | pubmed:citationSubset | IM | lld:pubmed |
pubmed-article:15269840 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:15269840 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:15269840 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:15269840 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:15269840 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:15269840 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:15269840 | pubmed:month | Aug | lld:pubmed |
pubmed-article:15269840 | pubmed:issn | 0340-6245 | lld:pubmed |
pubmed-article:15269840 | pubmed:author | pubmed-author:Espinola-Klei... | lld:pubmed |
pubmed-article:15269840 | pubmed:author | pubmed-author:RupprechtHans... | lld:pubmed |
pubmed-article:15269840 | pubmed:author | pubmed-author:BlankenbergSt... | lld:pubmed |
pubmed-article:15269840 | pubmed:author | pubmed-author:BickelChristo... | lld:pubmed |
pubmed-article:15269840 | pubmed:author | pubmed-author:DariusHaraldH | lld:pubmed |
pubmed-article:15269840 | pubmed:author | pubmed-author:MeyerJuergenJ | lld:pubmed |
pubmed-article:15269840 | pubmed:author | pubmed-author:SchlittAxelA | lld:pubmed |
pubmed-article:15269840 | pubmed:author | pubmed-author:LacknerKarl... | lld:pubmed |
pubmed-article:15269840 | pubmed:author | pubmed-author:HeineGunnar... | lld:pubmed |
pubmed-article:15269840 | pubmed:author | pubmed-author:DopheideJoern... | lld:pubmed |
pubmed-article:15269840 | pubmed:author | pubmed-author:IzMeteM | lld:pubmed |
pubmed-article:15269840 | pubmed:issnType | Print | lld:pubmed |
pubmed-article:15269840 | pubmed:volume | 92 | lld:pubmed |
pubmed-article:15269840 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:15269840 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:15269840 | pubmed:pagination | 419-24 | lld:pubmed |
pubmed-article:15269840 | pubmed:dateRevised | 2007-11-15 | lld:pubmed |
pubmed-article:15269840 | pubmed:meshHeading | pubmed-meshheading:15269840... | lld:pubmed |
pubmed-article:15269840 | pubmed:meshHeading | pubmed-meshheading:15269840... | lld:pubmed |
pubmed-article:15269840 | pubmed:meshHeading | pubmed-meshheading:15269840... | lld:pubmed |
pubmed-article:15269840 | pubmed:meshHeading | pubmed-meshheading:15269840... | lld:pubmed |
pubmed-article:15269840 | pubmed:meshHeading | pubmed-meshheading:15269840... | lld:pubmed |
pubmed-article:15269840 | pubmed:meshHeading | pubmed-meshheading:15269840... | lld:pubmed |
pubmed-article:15269840 | pubmed:meshHeading | pubmed-meshheading:15269840... | lld:pubmed |
pubmed-article:15269840 | pubmed:meshHeading | pubmed-meshheading:15269840... | lld:pubmed |
pubmed-article:15269840 | pubmed:meshHeading | pubmed-meshheading:15269840... | lld:pubmed |
pubmed-article:15269840 | pubmed:meshHeading | pubmed-meshheading:15269840... | lld:pubmed |
pubmed-article:15269840 | pubmed:meshHeading | pubmed-meshheading:15269840... | lld:pubmed |
pubmed-article:15269840 | pubmed:meshHeading | pubmed-meshheading:15269840... | lld:pubmed |
pubmed-article:15269840 | pubmed:meshHeading | pubmed-meshheading:15269840... | lld:pubmed |
pubmed-article:15269840 | pubmed:meshHeading | pubmed-meshheading:15269840... | lld:pubmed |
pubmed-article:15269840 | pubmed:meshHeading | pubmed-meshheading:15269840... | lld:pubmed |
pubmed-article:15269840 | pubmed:meshHeading | pubmed-meshheading:15269840... | lld:pubmed |
pubmed-article:15269840 | pubmed:meshHeading | pubmed-meshheading:15269840... | lld:pubmed |
pubmed-article:15269840 | pubmed:meshHeading | pubmed-meshheading:15269840... | lld:pubmed |
pubmed-article:15269840 | pubmed:meshHeading | pubmed-meshheading:15269840... | lld:pubmed |
pubmed-article:15269840 | pubmed:meshHeading | pubmed-meshheading:15269840... | lld:pubmed |
pubmed-article:15269840 | pubmed:meshHeading | pubmed-meshheading:15269840... | lld:pubmed |
pubmed-article:15269840 | pubmed:meshHeading | pubmed-meshheading:15269840... | lld:pubmed |
pubmed-article:15269840 | pubmed:year | 2004 | lld:pubmed |
pubmed-article:15269840 | pubmed:articleTitle | CD14+CD16+ monocytes in coronary artery disease and their relationship to serum TNF-alpha levels. | lld:pubmed |
pubmed-article:15269840 | pubmed:affiliation | Department of Medicine II and Institute of Clinical Chemistry and Laboratory Medicine, Johannes Gutenberg University, Mainz, Germany. axelschlitt@gmx.net | lld:pubmed |
pubmed-article:15269840 | pubmed:publicationType | Journal Article | lld:pubmed |
entrez-gene:929 | entrezgene:pubmed | pubmed-article:15269840 | lld:entrezgene |
entrez-gene:2214 | entrezgene:pubmed | pubmed-article:15269840 | lld:entrezgene |
entrez-gene:7124 | entrezgene:pubmed | pubmed-article:15269840 | lld:entrezgene |
http://linkedlifedata.com/r... | entrezgene:pubmed | pubmed-article:15269840 | lld:entrezgene |
http://linkedlifedata.com/r... | entrezgene:pubmed | pubmed-article:15269840 | lld:entrezgene |
http://linkedlifedata.com/r... | entrezgene:pubmed | pubmed-article:15269840 | lld:entrezgene |
lhgdn:association:41322 | lhgdn:found_in | pubmed-article:15269840 | lld:lhgdn |
lhgdn:association:47865 | lhgdn:found_in | pubmed-article:15269840 | lld:lhgdn |
lhgdn:association:62367 | lhgdn:found_in | pubmed-article:15269840 | lld:lhgdn |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:15269840 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:15269840 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:15269840 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:15269840 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:15269840 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:15269840 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:15269840 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:15269840 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:15269840 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:15269840 | lld:pubmed |